141 related articles for article (PubMed ID: 19211378)
1. Extravasation of oxaliplatin: an infrequent and irritant toxicity.
Pericay C; López A; Soler JR; Bonfill T; Dotor E; Saigí E
Clin Transl Oncol; 2009 Feb; 11(2):114-6. PubMed ID: 19211378
[TBL] [Abstract][Full Text] [Related]
2. Management of extravasation of oxaliplatin.
de Lemos ML; Walisser S
J Oncol Pharm Pract; 2005 Dec; 11(4):159-62. PubMed ID: 16595069
[TBL] [Abstract][Full Text] [Related]
3. Vesicant characteristics of oxaliplatin following antecubital extravasation.
Kennedy JG; Donahue JP; Hoang B; Boland PJ
Clin Oncol (R Coll Radiol); 2003 Aug; 15(5):237-9. PubMed ID: 12924452
[TBL] [Abstract][Full Text] [Related]
4. Extravasations of oxaliplatin.
Kretzschmar A; Pink D; Thuss-Patience P; Dörken B; Reichert P; Eckert R
J Clin Oncol; 2003 Nov; 21(21):4068-9. PubMed ID: 14581435
[No Abstract] [Full Text] [Related]
5. A midline for oxaliplatin infusion: the myth of safety devices.
Masters B; Hickish T; Cidon EU
BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24903726
[TBL] [Abstract][Full Text] [Related]
6. A case report of oxaliplatin extravasation.
Foo KF; Michael M; Toner G; Zalcberg J
Ann Oncol; 2003 Jun; 14(6):961-2. PubMed ID: 12796037
[No Abstract] [Full Text] [Related]
7. [Reversible tissue damage after paravasal infusion of oxaliplatin].
Boesen C; Nielsen SE
Ugeskr Laeger; 2015 Jan; 177(4):V07140390. PubMed ID: 25613210
[TBL] [Abstract][Full Text] [Related]
8. Idiosyncratic reaction after oxaliplatin infusion.
Santini D; Tonini G; Salerno A; Vincenzi B; Patti G; Battistoni F; Dicuonzo G; Labianca R
Ann Oncol; 2001 Jan; 12(1):132-3. PubMed ID: 11249043
[No Abstract] [Full Text] [Related]
9. Acute immune hematological complication of oxaliplatin. A series of 3 cases.
Garciaz S; Oziel-Taieb S; Dermeche S; Ries P; Vessaud J; Raoul JL
Tumori; 2014; 100(1):e17-9. PubMed ID: 24675502
[TBL] [Abstract][Full Text] [Related]
10. Mediastinal extravasation of oxaliplatin.
Pijaume CP; Saigí E
Clin Adv Hematol Oncol; 2012 Aug; 10(8):548-9. PubMed ID: 23073057
[No Abstract] [Full Text] [Related]
11. A case of mitoxantrone extravasation.
Chang A
J Oncol Pharm Pract; 2020 Jul; 26(5):1270-1273. PubMed ID: 31902285
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate.
Levi F; Perpoint B; Garufi C; Focan C; Chollet P; Depres-Brummer P; Zidani R; Brienza S; Itzhaki M; Iacobelli S
Eur J Cancer; 1993; 29A(9):1280-4. PubMed ID: 8343268
[TBL] [Abstract][Full Text] [Related]
13. Renal toxicity of oxaliplatin.
Labaye J; Sarret D; Duvic C; Hérody M; Didelot F; Nédélec G; Noël LH
Nephrol Dial Transplant; 2005 Jun; 20(6):1275-6. PubMed ID: 15827046
[No Abstract] [Full Text] [Related]
14. Acute ototoxicity from a single infusion of oxaliplatin.
Malhotra NK; Aslam R; Lipman SP; Bilski VJ
Ear Nose Throat J; 2010 Jun; 89(6):258-61. PubMed ID: 20556736
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin: a new drug for the treatment of metastatic carcinoma of the colon or rectum.
Baker DE
Rev Gastroenterol Disord; 2003; 3(1):31-8. PubMed ID: 12684591
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature.
Cobo F; De Celis G; Pereira A; Latorre X; Pujadas J; Albiol S
Anticancer Drugs; 2007 Sep; 18(8):973-6. PubMed ID: 17667605
[TBL] [Abstract][Full Text] [Related]
17. Comparison of local reactions to oxaliplatin infusions by peripheral versus central venous administration.
To YY; Sutcliffe KJ; Hoen HM; Swaney RA; Nicholls JD; Crocenzi TS
J Oncol Pharm Pract; 2016 Apr; 22(2):256-60. PubMed ID: 25762052
[TBL] [Abstract][Full Text] [Related]
18. Anaphylactic reaction to oxaliplatin: a case report.
Larzillière I; Brandissou S; Breton P; Lingoungou A; Gargot D; Ramain JP; Harnois C
Am J Gastroenterol; 1999 Nov; 94(11):3387-8. PubMed ID: 10566767
[No Abstract] [Full Text] [Related]
19. Oxaliplatin-induced thrombotic thrombocytopenic purpura: case report and literature review.
Niu J; Mims MP
J Clin Oncol; 2012 Nov; 30(31):e312-4. PubMed ID: 22987080
[No Abstract] [Full Text] [Related]
20. Oxaliplatin hypersensitivity: case report and successful repeat desensitization.
Edmondson DA; Gruling BJ; Urmanski AM; Wong SJ; Levy MB
Am J Ther; 2007; 14(1):116-8. PubMed ID: 17303980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
